🇺🇸 Subgam in United States

36 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Erythema — 7 reports (19.44%)
  2. Chronic Kidney Disease — 4 reports (11.11%)
  3. Tubulointerstitial Nephritis — 4 reports (11.11%)
  4. Burning Sensation — 3 reports (8.33%)
  5. Chest Pain — 3 reports (8.33%)
  6. Infusion Site Erythema — 3 reports (8.33%)
  7. Infusion Site Pain — 3 reports (8.33%)
  8. Infusion Site Swelling — 3 reports (8.33%)
  9. Lip Pain — 3 reports (8.33%)
  10. Lip Ulceration — 3 reports (8.33%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Subgam approved in United States?

Subgam does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Subgam in United States?

Bio Products Laboratory is the originator. The local marketing authorisation holder may differ — check the official source linked above.